Estimating prevalence of genital warts in Turkey: Survey among KETEM-affiliated gynecologists across Turkey

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2397-2400

  Ozgul, Nejat ^a   Tuncer, Murat ^a   Abacioglu, Melike ^a   Gultekin, Murat ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

Genital warts; Gynecologists; Prevalence; Regions; Treatment; Turkey

Indexed keywords

ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; COST BENEFIT ANALYSIS; FEMALE; HUMAN; INCIDENCE; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; RISK FACTOR; TURKEY (REPUBLIC); UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; CONDYLOMATA ACUMINATA; COST-BENEFIT ANALYSIS; DATA COLLECTION; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; TURKEY; UTERINE CERVICAL NEOPLASMS;

EID: 84866273702     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Arbyn M, Bruni L, de Sanjosé S, et al (2011). Prevalence of human papillomavirus ifection and burden of cervical cancer in Europe in 2008. In: Ayhan A, Reed N, Gultekin M, Dursun P, eds. 2nd edition. Textbook of Gynecological Oncology. Ankara, Turkey: Gunes Publishing; 89-98.
2. Baseman JG, Koutsky LA (2005). The epidemiology of human papillomavirus infections. J Clin Virol, 32 Suppl, S16-24.
3. Beutner KR, Ferenczy A (1997). Therapeutic approaches to genital warts. Am J Med, 102, 28-37.
4. Castellsague X, Cohet C, Puig-Tintore LM, et al (2008). Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health, 19, 106-10.
5. Dunne EF, Unger ER, Sternberg M, et al (2007). Prevalence of HPV infection among females in the United States. JAMA 297, 813-19.
6. Edwards L, Ferenczy A, Eron L, et al (1998). Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human Papillomavirus. Arch Dermatol, 134, 25-30.
7. French L, Nashelsky J, White D (2002). What is the most effective treatment for external genital warts? J Fam Pract. 51:313.
8. Harper DM, Vierthaler SL (2012). Bivalent HPV Vaccine Approved for 6 Cervical Cancer Prevention in Females. In: Ayhan A, Reed N, Gultekin M, Dursun P, eds. 2nd edition. Textbook of Gynecological Oncology. Ankara, Turkey: Gunes Publishing; 127-45.
9. Hillemanns P, Breugelmans JG, Gieseking F, et al (2008). Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study. BMC Infectious Diseases, 8, 76.
10. Insinga RP, Dasbach EJ, Myers ER (2003). The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis, 36, 1397-403.
11. Koshiol JE, Laurent SA, Pimenta JM (2004). Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis, 31, 748-52.
12. Liaw KL, Glass AG, Manos MM, et al (1999). Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst, 91, 954-60.
13. Markowitz LE, Dunne EF, Saraiya M, et al (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 56 (RR-2), 1-24.
14. Monsonégo J., Breugelman JG, Bouée S. et al (2007). Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynécologie Obstétrique Fertilité, 35, 107-13.
15. Schiffman MH, Bauer HM, Hoover RN, et al (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst, 85, 958-64.
16. Tuncer AM, Moore M, Qiao YL, et al (2010). Asian Pacific Organization for Cancer Prevention Cancer Report 2010. Ankara, Turkey: SUVAK - New Hope in Health Foundation; 2010; 215-21.
17. Turkish Ministry of Health (2011). Online state database. 15 July 2011. Number of gynecologists in private, state and university hospitals.
18. Turkish Statistical Institution (2011). Population projections based on age and gender. http://tuik.gov.tr/VeriBilgi.do?tb_id=39&ust_id=11
19. Turkish Statistical Institution (2011). Average age at marriage and mean age at first marriage by Classification of Statistical Region Units, January-March 2010. http://www.tuik.gov.tr/PreHaberBultenleri.do?id=6280&tb_id=2
20. Tyring S, Edwards L, Cherry LK, et al (1998). Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts. Arch Dermatol, 134, 33-8.
21. von Krogh G, Lacey CJ, Gross G, et al (2000). European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect, 76, 162-8.
22. Walboomers JM, Jacobs MV, Manos MM et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
23. Wiley DJ (2003). Genital warts. Clin Evid, 9, 1741-53.